Abstract:Controlled ovarian stimulation is tailored to the patient based on clinical parameters but estimating the number of retrieved metaphase II (MII) oocytes is a challenge. Here, we have developed a model that takes advantage of the patient's genetic and clinical characteristics simultaneously for predicting the stimulation outcome. Sequence variants in reproduction-related genes identified by next-generation sequencing were matched to groups of various MII oocyte counts using ranking, correspondence analysis, and self-organizing map methods. The gradient boosting machine technique was used to train models on a clinical dataset of 8,574 or a clinical-genetic dataset of 516 ovarian stimulations. The clinical-genetic model predicted the number of MII oocytes better than that based on clinical data. Anti-Müllerian hormone level and antral follicle count were the two most important predictors while a genetic feature consisting of sequence variants in the GDF9 , LHCGR , FSHB , ESR1 , and ESR2 genes was the third. The combined contribution of genetic features important for the prediction was over one-third of that revealed for anti-Müllerian hormone. Predictions of our clinical-genetic model accurately matched individuals' actual outcomes preventing over- or underestimation. The genetic data upgrades the personalized prediction of ovarian stimulation outcomes, thus improving the in vitro fertilization procedure. Infertility is a condition that leads to the failure of natural conception. It affects more than 186 million people worldwide. Because in vitro fertilization (IVF) is an effective infertility treatment, optimizing the steps in the process is essential to best assist those trying to conceive. The IVF process begins with ovarian stimulation during which the woman takes ovary-stimulating hormones, i.e., gonadotropins, to produce a certain number of viable, fertilization-ready egg cells, but predicting the number of egg cells collected after such stimulation is difficult. These predictions are usually based on the patient's clinical parameters and depend on the physician's experience, making them highly subjective. Here, we used machine learning to identify features that physicians could adopt to predict the number of egg cells obtained after ovarian stimulation. We found that clinical parameters (anti-Müllerian hormone level and antral follicle count), as well as genetic characteristics (variants in reproduction-related genes— GDF9 , LHCGR , FSHB , ESR1 , and ESR2 ), are important features that increase the accuracy of such predictions. Our predictive model has been designed to help physicians tailor the protocols used for ovarian stimulation on a case-by-case basis, thereby improving the safety and efficiency of the IVF process.

The construction of machine learning-based predictive models for high-quality embryo formation in poor ovarian response patients with progestin-primed ovarian stimulation

A Clinician-Friendly Machine Learning System to Predict Ovarian Response and Deploy Individualized Ovarian Stimulation Strategies in IVF

Development and validation of a live birth prediction model for expected poor ovarian response patients during IVF/ICSI

Development and validation of a prediction model for unexpected poor ovarian response during IVF/ICSI

Machine Learning-Based Modeling of Ovarian Response and the Quantitative Evaluation of Comprehensive Impact Features

Machine-intelligence for developing a potent signature to predict ovarian response to tailor assisted reproduction technology

Preovulatory progesterone levels are the top indicator for ovulation prediction based on machine learning model evaluation: a retrospective study

Development and validation of a prediction model for suboptimal ovarian response in polycystic ovary syndrome (PCOS) patients undergoing GnRH-antagonist protocol in IVF/ICSI cycles

Nomogram to predict the probability of clinical pregnancy in women with poor ovarian response undergoing in vitro fertilization/ intracytoplasmic sperm injection cycles

Prospective observational cohort study: Computational models for early prediction of ongoing pregnancy in fresh IVF/ICSI-ET protocols

Enhancing clinical utility: deep learning-based embryo scoring model for non-invasive aneuploidy prediction

Construction of a Clinical Prediction Model for the Impact of Acupuncture on Pregnancy Outcomes in Poor Ovarian Response (POR) Patients Based on a Patient Registry Research Platform.

Constructing a predictive model for live birth following fresh embryo transfer in antagonist protocol for polycystic ovary syndrome

Personalized prediction of the secondary oocytes number after ovarian stimulation: A machine learning model based on clinical and genetic data

An Online Tool for Predicting Ovarian Responses in Unselected Patients Using Dynamic Inhibin B and Basal Antimüllerian Hormone Levels

Predictive models for live birth outcomes of FET: Improving clinical decision-making based on machine learning analysis

Machine Learning-Based Prediction of Pregnancy Outcomes in Couples with Non-Obstructive Azoospermia Using Micro-Tese for ICSI: a Retrospective Cohort Study

Prediction model of preeclampsia using machine learning based methods: a population based cohort study in China

A validated model for individualized prediction of pregnancy outcome in woman after fresh cycle of Day 5 single blastocyst transfer